Graham Calder Mullen
2013Annual
Ask Donna
Pull out the substance of this filing.
What was filed
76
investments
2
positions
0
gifts
0
agreements
0
debts
0
reimbursements
0
income
0
spouse income
Named parties
- Duke Umiversity Law School Board of Visitors
- Royal Crest Home Owners
As filed
BRANCH BANK & TRUST CO. (Bank Accounts) — Interest
Smith Bamey Money Market Fund (See explanation) — Int/Div
Smith Bamey Money Market Fund (See explanation) — Int/Div
Central Fund - Canada — Int/Div
Intel Corp — Int/Div
Merck & Co — Int/Div
Proctor & Gamble — Int/Div
General Electric — Int/Div
Chart Indus — None
TEVA Pharmaceuticals (See SELF- INITIATED AMENDMENT. Line 148) — Int/Div
IRA {See explanation) — Int/Div
Loomis Sayles Funds IT Strategic Inc Fund — Sold (part)
Oppenheimer Int'l Bond Fund — Sold (part)
Oppenheimer Int'l Small Co Fund — Sold (part)
Oppenheimer Int'l Small Co Fund — Sold (part)
Satuit Cap Micro Cap Fund — Sold (part)
Satuit Cap Micro Cap Fund — Sold (part)
Satuit Cap Micro Cap Fund — Sold (part)
Oppenheimer Gold & Sp. Minerals — Sold (part)
Fidelity Advisor SPR 1 Leveraged Co Hb Fund — Sold (part)
Permanent Portfolio Fd
Blackrock Global Allocation — Sold (part)
Columbia Select Large Cap Growth Fd — Sold (part)
Delaware Pooled TR Diversified Inc Fd
First Eagle Fds Global Fd — Sold (part)
First Eagle Fds Global Fd — Sold (part)
First Eagle Fds Global Fd — Sold (part)
Yacktman Fd — Sold (part)
S10.
Pimco Fds - Total Return Fd — Sold (part)
Pimco AllAsset AllAuthonity — Buy (add'l)
Royce Premier Fd — Sold (part)
Templeton Fds - TR Global Bd Advisor — Sold (part)
MFS - Int'l New Discovery Fd — Sold (part)
JP Morgan Core Bond FD Select
Neuberger Berman Income New Strategic Fd — Sold (part)
Hondo Mmerals Corp — None
ISORAY — None
Valero Energy — Int/Div — Sold
Mosaic — Int/Div — Sold (part)
GDX Goldmmers ETF — Int/Div — Sold
NORTHWESTERN MUTUAL (NML) INSURANCE POLICIES
Whole Life XXX113 — Int/Div
NML Whole Life XXXI88 — Int/Div
NML Whole Life XXX510 — Int/Div
NML Whole Life XXX698 — Int/Div
NML Extraord. Life 403 — Int/Div
NML Adjustable Comp XXX 100 — Int/Div
NML 65 Life 913 — Int/Div
NML 65 Life 473 — Int/Div
NML Whole Life 437 — Int/Div
NML Whole Life 800 — None
Select SPDR Energy — Int/Div
Prudent Bear Fund — None
Eldorado Gold — Int/Div — Sold
Click Software Tech. — None
Chart Indus — None — Sold (part)
Nanoviricides — None
Neural Stem Inc — None
International Stem Cell Corp — None
Galectin Therapeutics — None
Brigus Gold — None
Inovio Pharmaceuticals — None
Argentex Mining — None
CenturyLink Inc — Int/Div — Sold
Mast Therapeutics — None
Alliance Grain Traders — None
Clearbridge Energy (EMO) — Int/Div
First Trust Cloud Computing — Int/Div — Sold
Star Scientific — None — Sold
Star Scientific — Buy
Parkway Properties, formerly Thomas PPTY GRP. (See explanation, ) — None
SELF-INITIATED AMENDMENT, line 146 (See explanation)
Star Scientifc — None — Sold (part)
SELF-INITIATED AMENDMENT, line 149 (See explanation)
TEVA Pharmaceuticals — Int/Div — Buy
Homorary Lite Member, Duke Umiversity Law School Board of Visitors
Member HOA Board, Royal Crest Home Owners
Explanation of line items contained in Part VIL.
Lines 3 and 5 - Smith Barney Money Market fund includes deposits in that fund which the broker has moved into their Bank Deposit program.
Line 21 - The IRA was established from my Thrift Savings Plan, all capital gains and dividends are re-invested. Periodically, small numbers of shares are sold to
pay the trustee's fees. These are reported. This income is aggregated and not reported for each separate fund.
Line 141 - Parkway Properties was mitially purchased as Thomas PPTY Group. Thomas PPTY Group was acquired by Parker Property on 12/20/2013.
SELF-INITIATED AMENDMENTS TO THE 2012 REPORT.
Line 146 « Star Scientific was listed as "Sold" in 2012. However, it should have been listed as Sold (part).
Line 149 - TEVA Pharmaceuticals was inadvertently omitted in 2012.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.